Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Other Non-Current Assets: 2021-2025

Historic Other Non-Current Assets for InMed Pharmaceuticals (INM) over the last 4 years, with Sep 2025 value amounting to $100,000.

  • InMed Pharmaceuticals' Other Non-Current Assets changed negligibly% to $100,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $100,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $100,000 for FY2025, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, InMed Pharmaceuticals' Other Non-Current Assets stood at $100,000, which was down 0.00% from $100,000 recorded in Q2 2025.
  • Over the past 5 years, InMed Pharmaceuticals' Other Non-Current Assets peaked at $176,637 during Q2 2022, and registered a low of $8,625 during Q3 2021.
  • Moreover, its 3-year median value for Other Non-Current Assets was $100,000 (2025), whereas its average is $104,926.
  • Per our database at Business Quant, InMed Pharmaceuticals' Other Non-Current Assets skyrocketed by 1,884.12% in 2022 and then crashed by 41.56% in 2023.
  • Over the past 5 years, InMed Pharmaceuticals' Other Non-Current Assets (Quarterly) stood at $109,175 in 2021, then soared by 56.75% to $171,130 in 2022, then tumbled by 41.56% to $100,000 in 2023, then remained steady at $100,000 in 2024, then remained steady at $100,000 in 2025.
  • Its last three reported values are $100,000 in Q3 2025, $100,000 for Q2 2025, and $100,000 during Q1 2025.